Primary Care Provider Practices and Perceptions Regarding HPV Vaccination and Anal Cancer Screening at a Boston Community Health Center

Apaydin, Kaan Z.; Fontenot, Holly B.; Shtasel, Derri; Mayer, Kenneth H.; Keuroghlian, Alex S.

doi:10.1007/s10900-018-0486-0

Cited by 18 publications

(16 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Contributing factors for not identifying, screening, or referring at-risk patients may have been provider comfort level with discussing AC screening and performing anal cytology 14 providers’ unconfirmed assumptions regarding patients’ sexual orientation and practices, 15,16 and time constraints during clinic visits. 17 Consistent with our previous provider survey findings, male providers were less likely to refer their patients for screening, and the 2 highest referring providers to the clinic were female. 5 The lack of clinical trial data on the impact of AC screening adds uncertainty around the value of screening.…”

Section: Discussionsupporting

confidence: 87%

Establishing an Anal Cancer Screening Program in an Outpatient HIV Clinic: Referral Patterns and Patient Perceptions Survey

Sowah

Schmalzle

Khambaty

et al. 2020

J Int Assoc Provid AIDS Care

View full text Add to dashboard Cite

People living with HIV are at high risk for anal cancer (AC); however, the impact of screening for and treatment of precancerous anal lesions on AC incidence remains uncertain. In 2013, we conducted a survey of HIV providers evaluating the perceived need for an institutional AC screening program. Based on an overwhelmingly positive response, we established a dedicated AC screening clinic (including provision of high-resolution anoscopies) embedded within the institutional HIV clinic. Here, we describe that referral of high-risk patients in the first 3 years was lower than expected. Referral patterns suggest that screening practices vary widely among HIV providers within the institution. Anal cancer clinic patients who completed a perception survey rated the value of AC screening as high, with perceived positive health impact, and identified their providers as the main source of information on AC and AC screening. Our findings imply remaining provider-related barriers to AC screening.

show abstract

Section: Discussionsupporting

confidence: 87%

Establishing an Anal Cancer Screening Program in an Outpatient HIV Clinic: Referral Patterns and Patient Perceptions Survey

Sowah

Schmalzle

Khambaty

et al. 2020

J Int Assoc Provid AIDS Care

View full text Add to dashboard Cite

show abstract

“…Previous studies have shown that the decreased risk of AC seen in Hispanics and Asians may be due to more access to HPV vaccines at early ages (16). Access to HPV vaccines at an early age decreases the likelihood of being infected with any strains associated with AC (11,12,17).…”

Section: Discussionmentioning

confidence: 99%

Racial and gender disparities in the incidence of anal cancer: analysis of the Nationwide Inpatient Sample (NIS)

Cruz¹,

Chen²,

Hsu³

et al. 2018

J. Gastrointest. Oncol

View full text Add to dashboard Cite

Background: Racial and gender disparities have been shown in other gastrointestinal cancers. However, there is a paucity of data on racial and gender disparities in anal cancer (AC). The aim of this study was to assess racial and gender disparities among patients with AC. Methods: We analyzed data from the National Inpatient Sample (NIS) 2011 database of patients diagnosed with AC with age ≥18. Demographic data including age, race and gender were assessed. Patients were stratified based on race and gender. Log binomial regression was used to generate risk ratios. Results: A total of 6,013,105 patients were assessed and 1,956 (0.03%) patients had AC. Female patients were more at risk of developing AC [relative risk (RR): 1.14, P=0.02]. Whites and Blacks had the highest incidence followed by Asians/Pacific Islanders. Black males had increased risk of AC (RR: 1.43, P<0.01). Amongst Hispanics; both males (RR: 0.69, P=0.05) and females (RR: 0.46, P<0.0001) had decreased risk of developing AC. Finally, we saw that Asian females had a much lower risk of developing AC (RR: 0.33, P<0.01). Conclusions: Racial disparities and gender differences exist in the incidence of AC. Potential causes for this disparity are disparate access to healthcare, lack of education, and lack of awareness. Greater understanding of the racial disparity in AC can help identify at risk population and eventually lead to improved preventative measures to ultimately reduce the incidence of AC.

show abstract

“…In the last five years in Turkey, the reported prevalences of cervical cancer, vulvar cancer, anal cancer and penile cancer were 16.09%, 1.82%, 1.09%, and 0.16%, respectively (7). HPV vaccine is a proven method for preventing HPV-related cancers and genital warts, especially preventing cervical cancer (8,9). It is reported that vaccines containing HPV16-18 types prevent 63% of all HPV-related cancers; vaccines containing nine types of HPV (HPV6-11-16-18-31-33-45-52-58) provide protection against cervical, vulvar, vaginal, and anal cancers by 90% (6,10).…”

Section: According To Data From the Surveillance Program Conducted Bymentioning

confidence: 99%

Analysis of community-based studies related with knowledge, awareness, attitude, and behaviors towards HPV and HPV vaccine published in Turkey: A systematic review

Özdemir¹,

Akkaya²,

Karaşahin³

2020

J Turkish German Gynecol Assoc

View full text Add to dashboard Cite

Human papilloma virus (HPV) vaccine is a proven method for preventing HPV-related cancers and genital warts, especially preventing cervical cancer. It is aimed to systematically review and synthesize conclusions in detail from community-based studies published in Turkey between 2009 and 2019, which evaluate the knowledge, awareness, attitude, and behaviors of individuals towards HPV and HPV vaccination. This systematic review is conducted based on the PRISMA reporting method and includes community-based, descriptive cross-sectional and cross-sectional studies published between 2009 and 2019. In this systematic review, 5132 studies from six databases were scanned in total. It was determined that there were 23 studies that met the eligibility criteria for this systematic review. In the reviewed studies, it was determined that the rate of "Hearing of HPV before" was 3.8% at the lowest and 57.0% at the highest, and the rate of "Hearing of HPV vaccine before" was 2.2% at the lowest and 74.7% at the highest. In the reviewed studies, it was reported that although parents' willingness to have their daughters vaccinated with HPV vaccine varied between 14.4% and 68.0%, their willingness to have their sons vaccinated with HPV vaccine varied between 11.0% and 62.0%. In addition, it was reported that the lowest rate of vaccination with HPV vaccine among participants was 0.3% at the lowest and 6.0% at the highest. Consequently, it is considered that conducting common, systematic, and continuous health education programs aimed at both sexes and including both parents, which will increase the knowledge and awareness on HPV and its vaccine, would provide positive attitudes, and will be effective in protecting against HPV-related cancers.

show abstract

Primary Care Provider Practices and Perceptions Regarding HPV Vaccination and Anal Cancer Screening at a Boston Community Health Center

Cited by 18 publications

References 44 publications

Establishing an Anal Cancer Screening Program in an Outpatient HIV Clinic: Referral Patterns and Patient Perceptions Survey

Establishing an Anal Cancer Screening Program in an Outpatient HIV Clinic: Referral Patterns and Patient Perceptions Survey

Racial and gender disparities in the incidence of anal cancer: analysis of the Nationwide Inpatient Sample (NIS)

Analysis of community-based studies related with knowledge, awareness, attitude, and behaviors towards HPV and HPV vaccine published in Turkey: A systematic review

Contact Info

Product

Resources

About